Boston Scientific Scimed, Inc.

Ams Research Corporation

Medtronic Ps Medical, Inc.

Astora Women's Health, LLC

Medtronic, Inc.

Bayer Pharma Aktiengesellschaft

Medtronics Ps Medical, Inc.

Edouard A Koullick

Robert C Grant

Balkrishna S Jadhav

Robert E Lund

Paul V Trescony

Thomas Q Dinh

Justin M Crank

Hyun Wook Kang

Douglas Lawrence Evans

Micah D Thorson

Stuart F Watson

Michael T Beck

Samuel L Will

Somany Dy

John Fritz Otte

William Jeffrey Bertrand

Marc Hendriks

Mark S Bouchier

John Jason Buysman

Ross A Longhini

Rosa K Canifax

Richard F Murphy

Jonathan Schmidt

James B Presthus

The invention includes a shunt for at least partial implantation into a patient that includes an elongated conduit having at least one lumen therethrough, that includes a proximal end for receipt of bodily fluids for flow through the shunt and a distal end for discharge of the bodily fluids from the shunt, and a long term source of at least one occlusion resistant agent, wherein said at least a portion of the at least one occlusion resistant agent can permeate through at least a portion of the elongated conduit. The invention also includes kits and systems.

Cerebrospinal fluid shunt having long term anti-occlusion agent delivery

Described are methods, devices, and systems related to implants for the treatment of a female pelvic condition. The implants include absorbable and non-absorbable materials and can be introduced into the pelvic area transvaginally. Meshes of the invention provide benefits relating to improved tissue integration into the mesh, reduced infection likelihood, improved patient comfort following implantation, or combinations of thereof.

Implants with absorbable and non-absorbable features for the treatment of female pelvic conditions

Described are methods, devices, and systems related to pelvic implants, including implants that include absorbable and non-absorbable materials.

Bioabsorbable mesh for surgical implants

Embodiments of the invention are directed to a laser ablation system. In one embodiment, the laser ablation system comprises a shaft, a balloon, a laser fiber and a viewing fiber. The shaft has a proximal end and a distal end. The balloon is attached to the distal end of the shaft, a portion of which is within the balloon. The laser fiber has a distal end comprising a light dispenser that is configured to deliver laser light through the balloon. The viewing fiber is configured to image an interior balloon. In accordance with another embodiment, the laser ablation system comprises a shaft, a balloon and a laser fiber. The shaft has a proximal end and a distal end. The balloon is attached to the distal end of the shaft, which is within the balloon. The balloon includes an inflated state, in which the balloon is shaped to conform to a cavity of a patient. The laser fiber has a distal end comprising light dispenser that is configured to deliver laser light through the balloon.

Laser tissue ablation system

A composition and methods for improved delivery of a therapeutic agent to a stenosed vessel wall.

Catheter with drug coating

A shunt for at least partial implantation into a patient that includes an elongated conduit having at least one lumen therethrough and a second lumen concentric about the first lumen along at least part of the first lumen, that includes a proximal end for receipt of bodily fluids for flow through the shunt and a distal end for discharge of the bodily fluids from the shunt, and a long term source of at least one occlusion resistant agent, wherein said at least a portion of the at least one occlusion resistant agent can permeate through at least a portion of the elongated conduit. The invention also includes kits and systems.

Improved methods and apparatuses for treatment of incontinence or pelvic organ prolapse are provided. A neo ligament for increasing the supportive function of the tissues supporting the urethra, bladder neck, or rectum is disclosed. Methods of using such a neoligament to treat incontinence are disclosed. Additionally, a self tensioning elastic tissue bolster for support of the tissues that support the urethra, rectum, and bladder neck are disclosed. A method of treating incontinence by injecting proliferative agents into supportive structures is disclosed. Methods and apparatus for transvaginal and transperineal pelvic floor bolster treatment of incontinence and bladder pillar systems are also disclosed.

Method and articles for treatment of stress urinary incontinence

A uterine fibroid treatment device providing for localized delivery of one or more treatment drugs for treating various uterine conditions including, for example, uterine fibroids, abnormal uterine bleeding, pelvic adhesions and endometriosis. Generally, the uterine treatment device comprises a physical positioning element that can be inserted, positioned and maintained in close proximity to the uterine tissue to be treated. The treatment drugs delivered to the treatment location can include various combinations of anti-proliferative agents and angiogenesis inhibitors to provide different treatments concurrently. In some embodiments, the physical element can also serve the dual purpose of delivering the treatment drugs while simultaneously cutting off blood flow to a mature fibroid to initiate hypoxic/ischemic conditions within the mature fibroid.

Apparatus and methods of treatment of pathologic proliferative conditions uterine tissue

An occlusion resistant medical shunt, particularly a hydrocephalic shunt, is provided for implantation into a mammal. The shunt has an elongate wall structure configured as a tube having a lumen therethrough and a proximal end for receipt of bodily fluids. The bodily fluids, such as cerebrospinal fluid, flows through the shunt to a distal end for discharge of the bodily fluids. The wall structure of the shunt generally includes a biocompatible medical device material. The shunts of the present invention further include one or more occlusion resistant materials to resist occlusion of the lumenal passage in the shunt.

Occlusion resistant hydrocephalic shunt

Growing community of inventors

Minnetonka, MN, United States of America

Edouard A Koullick